China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
54 hedge funds and large institutions have $724M invested in China Biologic Products Holdings, Inc. in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 4 reducing their positions, and 9 closing their positions.
475% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 4
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
22% more capital invested
Capital invested by funds: $593M → $724M (+$131M)
15% more funds holding
Funds holding: 47 → 54 (+7)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
69% less call options, than puts
Call options by funds: $367K | Put options by funds: $1.17M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.56M |
| 2 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$3.42M |
| 3 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$1.7M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.36M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.99M |
| 2 |
Morgan Stanley
New York
|
-$3.89M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$2.21M |
| 4 |
PHK
Point72 Hong Kong
Hong Kong
|
-$2.17M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$534K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
51
UBS
Zurich,
Switzerland
| $54K | +$49.2K | +1,000 | New |
|
|
OA
52
OFI Advisors
Philadelphia,
Pennsylvania
| $17K | +$3K | +61 | +24% |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| $13K | +$7.38K | +150 | +150% |
|
54
Creative Planning
Overland Park,
Kansas
| $5K | +$4.53K | +92 | New |
|
|
55
Fidelity Investments
Boston,
Massachusetts
| – | -$7.99M | -179,600 | Closed |
|
|
PHK
56
Point72 Hong Kong
Hong Kong
| – | -$2.17M | -48,815 | Closed |
|
57
Jane Street
New York
| – | -$521K | -11,720 | Closed |
|
|
58
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$534K | -10,858 | Closed |
|
|
LCM
59
Laurion Capital Management
New York
| – | -$374K | -8,400 | Closed |
|
60
Point72 Asset Management
Stamford,
Connecticut
| – | -$356K | -8,000 | Closed |
|
|
VKH
61
Virtu KCG Holdings
New York
| – | -$323K | -7,253 | Closed |
|
|
TRCT
62
Tower Research Capital (TRC)
New York
| – | -$50K | -1,131 | Closed |
|
|
GSC
63
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$9K | -200 | Closed |
|
CBPO Hedge Fund Activity: Q3 2014 in Review
54 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q3 2014, worth a combined $724M — up 22% from $593M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CBPO positions and 9 closed out — a net gain of 8 holders — while 23 added to existing stakes and 4 trimmed.
The largest buyer was Putnam Investments, opening a new position worth an estimated $3.56M. The largest seller was Fidelity Investments, exiting entirely with an estimated $7.99M sold.
- 54 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q3 2014, up from 47 in Q2 2014.
- Funds reported $724M of China Biologic Products Holdings, Inc. stock for Q3 2014, up 22% quarter-over-quarter.
- 17 funds opened new China Biologic Products Holdings, Inc. positions in Q3 2014 and 9 closed out, a net change of +8 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q3 2014 was Putnam Investments, an estimated $3.56M added.
- The largest China Biologic Products Holdings, Inc. seller in Q3 2014 was Fidelity Investments, an estimated $7.99M sold.
Based on aggregated 13F filings for Q3 2014.